A carregar...
The role of vasodilators in the prevention and treatment of no‐reflow following percutaneous coronary intervention
The routine use of vasodilators in patients with acute coronary syndromes or other groups undergoing percutaneous coronary intervention (PCI) cannot be recommended at present. However, in the event of no‐reflow occurring following PCI, intracoronary adenosine or verapamil should be administered
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Group
2006
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1861163/ https://ncbi.nlm.nih.gov/pubmed/16606861 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/hrt.2006.088427 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|